1. Home
  2. SHLT vs ICCC Comparison

SHLT vs ICCC Comparison

Compare SHLT & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHLT
  • ICCC
  • Stock Information
  • Founded
  • SHLT 1987
  • ICCC 1982
  • Country
  • SHLT Israel
  • ICCC United States
  • Employees
  • SHLT N/A
  • ICCC N/A
  • Industry
  • SHLT Business Services
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHLT Consumer Discretionary
  • ICCC Health Care
  • Exchange
  • SHLT Nasdaq
  • ICCC Nasdaq
  • Market Cap
  • SHLT 46.9M
  • ICCC 45.9M
  • IPO Year
  • SHLT N/A
  • ICCC 1987
  • Fundamental
  • Price
  • SHLT $2.72
  • ICCC $5.20
  • Analyst Decision
  • SHLT Strong Buy
  • ICCC
  • Analyst Count
  • SHLT 1
  • ICCC 0
  • Target Price
  • SHLT $11.00
  • ICCC N/A
  • AVG Volume (30 Days)
  • SHLT 3.3K
  • ICCC 7.3K
  • Earning Date
  • SHLT 09-26-2024
  • ICCC 02-25-2025
  • Dividend Yield
  • SHLT N/A
  • ICCC N/A
  • EPS Growth
  • SHLT N/A
  • ICCC N/A
  • EPS
  • SHLT N/A
  • ICCC N/A
  • Revenue
  • SHLT $55,939,000.00
  • ICCC $23,838,001.00
  • Revenue This Year
  • SHLT N/A
  • ICCC N/A
  • Revenue Next Year
  • SHLT N/A
  • ICCC N/A
  • P/E Ratio
  • SHLT N/A
  • ICCC N/A
  • Revenue Growth
  • SHLT N/A
  • ICCC 46.37
  • 52 Week Low
  • SHLT $2.54
  • ICCC $3.34
  • 52 Week High
  • SHLT $7.96
  • ICCC $5.82
  • Technical
  • Relative Strength Index (RSI)
  • SHLT 39.44
  • ICCC 51.44
  • Support Level
  • SHLT $2.71
  • ICCC $5.00
  • Resistance Level
  • SHLT $2.85
  • ICCC $5.50
  • Average True Range (ATR)
  • SHLT 0.11
  • ICCC 0.32
  • MACD
  • SHLT -0.01
  • ICCC -0.05
  • Stochastic Oscillator
  • SHLT 0.00
  • ICCC 53.12

About SHLT SHL Telemedicine Ltd

SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: